Target species
Pigs.
Indications for use
For active immunisation of pigs to prevent clinical signs of Erysipelas disease caused by all relevant Erysipelothrix rhusiopathiae serotypes (serotype 1 and 2).
Onset of immunity: 3 weeks
Duration of immunity: 6 months
Contraindications
None.
Special warnings for each target species
Vaccinate healthy animals only.
Special precautions for use
Sick and weak animals should not be vaccinated.
Operator Warnings
In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
Adverse reactions
In laboratory studies and field trials:
Transient increases in body temperature (0.5 °C) within 24 hours may very commonly occur. Mild transient local swelling (Ø 1-10 mm) until 8 days after vaccination may very commonly occur. Transient reluctance to move may commonly occur.
In post marketing experience:
In very rare cases, a hypersensitivity reaction may occur.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Use during pregnancy, lactation or lay
Can be used during pregnancy and lactation.
Interactions
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except Porcilis Parvo vaccine. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Amounts to be administered and administration route
Administer one dose of 2 ml by deep intramuscular injection behind the ear.
Initial vaccination:
A single dose of vaccine in pigs from an age of 10 weeks onwards.
Repeat vaccination 4 weeks later.
Booster vaccination:
Revaccinations should be twice a year.
Before using vaccine allow it to reach room temperature (15 °C – 25 °C)
Shake vial before and regularly during use.
Use sterile syringe and needles. Avoid introduction of contamination by multiple broaching.
Overdose
Reactions observed after administration of a double dose are not different from those observed after administration of a single dose.
Withdrawal period(s)
Zero days.